Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$23,876,609
+$4,201,594 QoQ
Shares Held
94,884
+4.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#553
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,006,560
PutShares
4,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sequoia Financial Advisors, LLC holds $404,940,719 across 16 Drug Manufacturers - General names. ABBV ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
154,543 | $185,363,525 | |
| 2 | AMGN |
Amgen Inc
|
173,024 | $62,655,450 | |
| 3 | JNJ |
Johnson & Johnson
|
203,267 | $51,623,719 | |
| 4 | MRK |
Merck & Co., Inc.
|
292,117 | $37,537,034 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
94,884 | $23,876,609 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
179,874 | $10,364,339 | |
| 7 | PFE |
Pfizer Inc
|
332,178 | $7,998,846 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
58,662 | $7,411,357 |
All Filings in ABBV
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,876,609 | 94,884 | Shares | Sole | 2026-07-17 | |
| 2026-06-30 | $1,006,560 | 4,000 | Put | Sole | 2026-07-17 | |
| 2026-03-31 | $19,675,015 | 90,464 | Shares | Sole | 2026-04-30 | |
| 2026-03-31 | $869,960 | 4,000 | Put | Sole | 2026-04-30 | |
| 2025-12-31 | $20,944,078 | 91,663 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $19,563,740 | 84,494 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $55,686 | 300 | Call | Sole | 2025-07-25 | |
| 2025-06-30 | $14,795,584 | 79,709 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $16,043,574 | 76,573 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $12,367,031 | 69,595 | Shares | Sole | 2025-08-08 | |
| 2024-09-30 | $13,517,308 | 68,449 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $9,502,379 | 55,401 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $9,872,005 | 54,212 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $10,086,222 | 65,085 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $5,837,487 | 39,162 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,060,862 | 37,563 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,964,581 | 37,426 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $5,915,087 | 36,601 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,874,774 | 43,773 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $7,136,337 | 46,594 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $8,908,917 | 54,956 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,045,461 | 74,191 | Shares | Sole | 2022-02-22 | |
| 2021-09-30 | $1,561,418 | 14,475 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $6,378,465 | 56,627 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $4,954,203 | 45,779 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,751,995 | 44,349 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,541,438 | 40,432 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $3,787,882 | 38,581 | Shares | Sole | 2020-08-25 | |
| 2020-03-31 | $2,642,802 | 34,687 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||